Study Selection: Magnetic resonance imaging studies that examined differences in brain volumes between first degree relatives of patients with schizophrenia and healthy control subjects were obtained through computerized da tabases, including MEDLINE. Studies had to report suf ficient data for computation of effect sizes.
S

TRUCTURAL BRAIN ABNORMALI
ties are well established in schizophrenia. Several meta analyses 1, 2 have reported smaller brain volumes in schizophrenia, with more pronounced re ductions in the hippocampus and amyg dala. However, the nature of these brain changes is still unresolved. For instance, whether these changes are a result of the use of antipsychotic medication is a mat ter of debate. [3] [4] [5] [6] Similarly, it is unclear to what extent these abnormalities are re lated to the vulnerability for developing the illness. Both issues can be (partially) ad dressed by studying brain structures in relatives of patients with schizophrenia.
Clearly, the vulnerability for developing schizophrenia is highly genetic: studies 7 in families of patients with schizophrenia have shown that the origin of the disorder has an estimated heritability of 80%, includ ing interaction between the genes and en vironment. Thus, the presence of brain changes in relatives of patients would sug gest these to be related to the shared ge netic risk of developing schizophrenia. Moreover, brain volume differences in rela tives cannot be the result of antipsychotic medication. Therefore, examining brain vol umes in nonpsychotic first-degree rela tives of schizophrenic patients can clarify some of the causes of the brain abnormali ties observed in probands.
In recent years, several studies have measured brain volumes in nonpsychotic relatives of schizophrenic pa tients compared with those of healthy subjects. Most of these studies [8] [9] [10] [11] [12] [13] [14] [15] [16] showed smaller total brain volumes in relatives, but others [17] [18] [19] did not. Similarly, larger ven tricular volume has been reported in several stud ies, 14, 16, [19] [20] [21] [22] but 2 other studies did not find this. 12, 23 Fur thermore, medial temporal lobe structures were reportedly smaller in several studies, 9, 17, 19, [24] [25] [26] [27] but this finding has not been universally replicated. 8, 11, 16, 20, 28 Thus, although brain abnormalities have been found in first-degree rela tives of schizophrenic patients, the findings are incon sistent. Moreover, effect sizes in the individual studies have not been quantitatively reviewed and integrated.
The aim of the present meta-analysis was to determine the magnitude and extent of brain volume differences in first-degree relatives of schizophrenic patients. We at tempted to integrate the findings from magnetic reso nance imaging (MRI) studies in relatives of patients with schizophrenia. To this end, we examined volumes of global brain structures and smaller structures in nonpsychotic first degree relatives of patients with schizophrenia compared with those of healthy control subjects. In an additional analy sis, we compared brain volumes of patients with those of the unaffected relatives.
METHODS
DATA SOURCES
The MRI studies that examined differences in brain volumes in first-degree relatives of patients with schizophrenia com pared with healthy control subjects were obtained through com puterized databases, including MEDLINE. 
STUDY SELECTION
Forty-three studies were identified as potential candidates for the meta-analysis. Studies were included if (1) they were MRI studies of brain structures published before July 2005 or they
were not yet published but were presented as an abstract at the International Congress on Schizophrenia Research in 2005, (2) they compared first-degree relatives of patients with schizo phrenia with a healthy control group (having no history and family history of psychosis), (3) they were published in the En glish language, and (4) they reported sufficient data to obtain the effect size: means, standard deviations, exact P values, or exact F values for a 2-group comparison. Studies in which some of the relatives had an ill family member diagnosed as having schizoaffective disorder (instead of schizophrenia) were also included in this analysis.
Fifteen studies were excluded from the meta-analysis because they did not show relevant data to enable us to compute the Cohen d values. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] Five studies were excluded because they did not report brain volumes of relatives of schizophrenic pa tients compared with healthy control subjects. [43] [44] [45] [46] [47] Twenty-five studies were identified as suitable for our meta-analysis and in cluded 1065 independent first-degree relatives of patients, 679 patients with schizophrenia, and 1100 control subjects. The 25 studies that were identified as suitable reported brain volumes of different types of first-degree relatives; namely, siblings,* monozygotic twins, 10, 11, 14, 16, 25, 27, 49 dizygotic twins, 11, 14, 25, 27, 49 par ents, 15, 17, 18, 21, 28, 48, 50, 51 and offspring. 24 Four studies did not specify first-degree relatives. 8, 19, 21, 26 Together, the 25 studies re ported volumes of 56 brain structures. Some of these structures were not evaluated by more than 3 studies, and in this case, these structures were not examined in the analysis. Table 1 lists the included articles and the brain structures that were analyzed.
DATA EXTRACTION
This meta-analysis was performed to examine measurements of volumes in global brain structures and smaller structures in the medial temporal lobe in nonpsychotic first-degree rela tives of schizophrenic patients and healthy control subjects. The structures that were suitable for analysis included total brain, intracranial, lateral ventricle, third-ventricle, gray matter, white matter, amygdala-hippocampal, hippocampal, and cerebrospi nal fluid volume. If sufficient data were present, an analysis was performed to examine the effect of the side of the brain and differences in volumes between patients and relatives.
The key to meta-analysis is defining an effect size statistic ca pable of representing the quantitative findings of a set of research studies in a standardized form that permits meaningful compari son and analyses across the studies. 52 Therefore, for each study in this meta-analysis, the effect size statistic Cohen d was cal culated. The Cohen d is the difference between the mean of the experimental group and the mean of the comparison group di vided by the pooled standard deviation. In this analysis, the mean volume of a specific brain structure for relatives of patients with schizophrenia was subtracted from the mean volume for com parison subjects and divided by the pooled standard deviation of both. When means and standard deviations were not avail able, d values were calculated from exact P values, t values, or F values. Data extraction and computation of the effect sizes were performed independently by 2 of the authors (H.B.M.B. and A.A.). In cases of discrepancies, a consensus was reached by means of discussion. After computing individual effect sizes for each study, meta-analytic methods were applied to obtain a combined effect size, which indicated the magnitude of the association across all studies. 53 Individual effect sizes were inverse variance weighted to correct for upwardly biased estimation of the effect in small sample sizes. 53, 54 Additionally, a homogeneity statistic, Q, was calculated to test whether the studies could be assumed to share a common population effect size. A significant Q statistic indi cates heterogeneity of the individual study effect sizes, which poses a limitation to a reliable interpretation of the results. If sig nificant heterogeneity is found, a moderator analysis can be per formed to investigate the potential moderating factors. 54 A t test was subsequently performed on the null hypothesis that the d value is 0.00, which we report together with the associated P value. 9, 12, 13, 16-18, 20, 22, 23, 48 . All analyses were performed with a random-effects model using comprehensive meta-analysis. 56 A random-effects model assumes that the true effect size estimated by different studies varies among studies because of differences in samples or paradigms and that these true effect sizes have a normal distribution (ie, heterogeneity exists). 57 To examine the possibility of publication bias, we com puted a fail-safe number of studies. 54, 58 Publication bias im plies that studies with no effect may not be published, posing a threat to the stability of the obtained effect size. The fail-safe number of studies indicates the number of unpublished stud ies with null effects that must reside in file drawers to reduce the observed effect size to a negligible level. The statistic can be calculated with the use of the formula given by Orwin 58 and Lipsey and Wilson In this formula, k is the number of studies, ES k , the mean weighted effect size; and ES c , the criterion effect size (which we set at a d value of 0.10).
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DATA SYNTHESIS
The structures that were analyzed, the number of studies in cluded, and the number of subjects in which the structures were measured are reported in Table 1 . The composite effect sizes (Cohen d, associated confidence intervals, Q statistics, and P values) of all studies for the different structures are reported in Table 2 . Only those structures for which the volumes were explored in more than 3 individual studies were analyzed. In applicable studies, brain volumes of patients were also com pared with those of relatives. Table 2 , the results of our meta-analysis indicate brain volume differences between first-degree relatives of patients with schizophrenia and healthy con trol subjects. The largest effect was found for hippocam pal volume, with smaller volumes in relatives compared with healthy subjects (Figure 1) . In this analysis, 9 stud ies were included, with a group size of 421 relatives of patients with schizophrenia and 603 healthy control sub jects. One of the studies that measured hippocampal vol umes controlled for intracranial volume and 8 studies for whole brain volume. The combined-effect Cohen d of the 9 studies was 0.31 (P�.001). Excluding the studies that controlled for intracranial volume did not change the re sults, and analyzing studies (n=12) that measured hip pocampal together with amygdala volume even showed a combined-effect Cohen d of 0.52 (P =.005). The larg est effect was found in left hippocampal volume (d=0.47; P=.04; right hippocampal volume: d=0.23; P=.04). When we measured hippocampal volume in relatives com pared with control subjects, the fail-safe number was 18, large enough to lend credence to our findings.
RESULTS
As presented in
Small effects were found in cerebral gray matter (smaller in relatives vs healthy control subjects; d=0.18; P = .04; fail-safe number = 7) (Figure 2 ) and third ventricle volume (larger in relatives than in healthy con trol subjects; d = 0.21; P = .02; fail-safe number = 8) (Figure 3) . The analysis of gray matter volume in cluded 7 studies, with a group size of 249 relatives and 285 healthy control subjects. The analysis of third (REPRINTED) (d = 0.43; P = .001; 95% confidence interval, 0.17-0.68) with patients having smaller hippocampal volumes than relatives. This result showed significant heterogeneity (Q=22.28; P =.004). However, one study was an outlier, reporting a large decrease in hippocampal volume. 46 When we excluded this study, the heterogeneity was not sig nificant (d = 0.29; P�.001; Q = 2.67; P = .91). The fail safe number of studies for this analysis was 29, large enough to lend credence to our findings.
In the analysis that compared first-degree relatives with healthy control subjects, most Q values were nonsignifi cant ( Table 2 ) except for those in the analyses of amygdala hippocampal complex volume, white matter volume, total brain volume, and cerebrospinal fluid volume. This sig nificant Q value indicates heterogeneity of the indi vidual study effect sizes and thus limits reliable inter pretation of these results.
COMMENT
This meta-analysis integrated the results of 25 MRI stud ies that compared brain volumes of 1065 nonpsychotic first-degree relatives of patients with schizophrenia with those of 1100 healthy control subjects. The results indi cate that brain volumes in relatives of patients with schizo phrenia differ from those of healthy control subjects, with effect sizes in the small to moderate range. The largest effect is found in hippocampal volume (d=0.31), with ( 
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WWW.ARCHGENPSYCHIATRY.COMrelatives of patients having smaller volumes than healthy control subjects. In addition, total gray matter volume (d=0.18) and third-ventricle (d=0.21) volume are smaller in relatives compared with healthy control subjects. Al though total brain and white matter volume did not dif fer significantly in relatives compared with healthy con trols, both structures showed a trend toward significance (P=.06 and P=.07, respectively). The analysis that com pared patients with schizophrenia with first-degree rela tives showed smaller hippocampal volumes in the pa tients (d=0.43). In addition, 3 studies that were excluded from this meta-analysis examined hippocampal vol umes in first-degree relatives compared with healthy con trol subjects. Two studies also showed smaller volumes in relatives compared with healthy controls. 32, 36 How ever, Harris et al 33 did not find this. The results of this meta-analysis suggest that brain ab normalities in schizophrenia are related (in part) to the risk of developing the disease and that these brain changes may therefore predate the clinical onset of the disorder. Moreover, they argue against the notion that the brain abnormalities in schizophrenia are solely caused by an tipsychotics. These conclusions are bolstered by the find ing that the brain structures affected in relatives are the same as those reported to be abnormal in patients. 2 The findings are supported by 2 studies 59,60 that reported re duced gray matter volumes in similar brain structures of individuals at high risk for schizophrenia. Both studies reported that those relatives who later develop psy chotic symptoms have a more severe reduction before the onset of these symptoms.
The finding of hippocampal volume reduction in rela tives of schizophrenic patients also dovetails with the re sults of recent meta-analyses regarding cognitive func tioning in relatives. 61, 62 In these articles, lower performance in relatives of patients compared with healthy control sub jects was reported on several cognitive domains, includ ing verbal and declarative memory, executive function ing, and attention. Interestingly, Sitskoorn et al 62 found that the largest effect size was obtained for verbal memory (d = 0.54), being significantly worse in relatives of pa tients than in healthy subjects. However, the perfor mance of relatives on these cognitive tasks was less impaired than has been reported in patients with schizo phrenia. 63, 64 Indeed, decreased verbal memory is one of the most robust neuropsychological findings in schizo phrenia. 60 Deficits in verbal memory have generally been associated with smaller (left) hippocampal volume, 65 as is also the case in patients with schizophrenia 66, 67 and their relatives. 17, 26 In the present meta-analysis, the effect size was considerably larger for the left than for the right hippocampus. This finding is consistent with findings from lesion and functional MRI studies in healthy sub jects, suggesting more involvement of the left hippo campus in encoding and recognition of verbal as op posed to visual or pictorial material. 68 The suggestion of smaller left hippocampal volume as a vulnerability indi cator for schizophrenia, put forward by Seidman et al, 17 is also consistent with these observations. The findings of this meta-analysis suggest that a com mon genetic vulnerability to developing schizophrenia is reflected in brain morphologic findings. McDonald et al 69 demonstrated that the genetic risk of schizophrenia is associated with an extensive system of gray matter defi cits and white matter abnormalities. However, only a few studies have identified specific genes in relation to brain volume abnormalities in schizophrenia. Szeszko et al 70 studied 19 patients with schizophrenia and 25 healthy control subjects and reported a role for brain-derived neu rotropic factor in determining hippocampal volume. More relevant to the finding of the current meta-analysis, Cal licott et al 71 examined the effects of the DISC1 gene on the risk of schizophrenia and its impact on the hippo campus. They found that DISC1 increased the risk of de veloping the disease and was also associated with struc tural and functional alterations in the hippocampus.
However, smaller hippocampal volumes in relatives of patients with schizophrenia could also have been caused by environmental factors. Obstetric complications such as hypoxia are known to result in smaller brain vol umes, affecting the hippocampus profoundly. 21, 72, 73 Smaller hippocampal volumes have also been associated with brain injury 65, 74, 75 and stress 65, 76 and have been found not only in schizophrenia but also in several other psychiatric dis orders, such as major depression, posttraumatic stress dis order, obsessive-compulsive disorder, and borderline per sonality disorder. 65 An important function of the hippocampus and amygdala is the regulation of the hy pothalamic-pituitary-adrenal axis, which plays a role in stress processing. This regulation may be altered because of a genetic predisposition. In depression, the hy pothalamic-pituitary-adrenal axis is strongly activated and the adrenal cortex hypersecretes glucocorticoids such as cortisol. Although less pronounced, considerable hypo thalamic-pituitary-adrenal activation is also found in schizophrenia. 77 On the basis of earlier animal experi ments, overexposure to cortisol during prolonged peri ods of stress is expected to damage the brain, particu larly the hippocampus. Sapolsky et al 77 provided evidence in rats that chronic stress, with the concomitant increase in corticoid levels, causes loss of neurons in the hippocampus and subsequent deficits in memory func tion and cognition. In patients with depression, this glu cocorticoid cascade has also been presumed to result in decreased hippocampal volume, 78 possibly explained by apoptosis. 79 Both apoptosis and neurogenesis have been shown to occur in the hippocampus. 80 Thus, smaller hip pocampal volumes in patients with schizophrenia and their first-degree relatives might also be the result of stress related processes in the brain. 81 These hypotheses regarding putative genetic and en vironmental factors underlying hippocampal damage in relatives of schizophrenic patients can be integrated by taking gene-environment interactions into account. Gene environment interactions may result from genetically me diated differences in the sensitivity to environmental fac tors or environmentally mediated influences on gene expression. Evidence of genetically mediated differ ences in environmental factor sensitivity shows that slightly elevated rates of obstetric complications are found not only in patients with schizophrenia but also in their nonpsychotic first-degree relatives. 82, 83 As reported by Cannon et al, 83 most of these relatives exposed to obstetric complications did not develop schizophrenia, and thus (REPRINTED) 9 examined siblings of pa tients with schizophrenia and found that hippocampal volumes differed stepwise with each increase in genetic predisposition to schizophrenia and that hippocampal vol umes of patients exposed to fetal hypoxia were smaller than those who were unexposed, whereas no such rela tionship was observed within the healthy control sub jects. They suggested that carrying susceptibility genes for schizophrenia makes one vulnerable to perinatal dam age, especially in the hippocampus.
Some limitations of this meta-analysis should be noted. First, as with all meta-analyses, the results depend on the quality of the individual studies. The adjustment of ce rebral structures for whole brain or intracranial volume has been thought to facilitate differences in effects among the studies. However, the results of a moderator vari able analysis failed to confirm this hypothesis. There fore, it is unlikely that the observed differences in vol ume are due to differences in adjustment.
Second, structures other than those that have been evaluated in this meta-analysis may also be affected in relatives of patients with schizophrenia. The results of smaller hippocampal volumes in relatives compared with healthy control subjects might reflect broader abnor malities in the temporal lobes or even other structures, but because of the small amount of studies that mea sured these structures, this could not be investigated in our analysis.
Third, the results may have been influenced by pub lication bias. However, in the present meta-analysis, this is unlikely given a fail-safe number of studies statistic, which indicates the number of studies with null effects that must reside in file drawers before results of the ob tained effect sizes are reduced to a negligible level.
Fourth, only a few studies that were included in the meta-analysis and measured brain volumes of siblings specified whether they had used independent samples or multiple siblings per family. Although this may bring in a confounding factor, because of the small number of stud ies in the meta-analysis, all sibling studies that were avail able and met the criteria were included. Fifth, differences in age and sex were not examined. Age and sex are known to affect brain volumes 83 ; how ever, the studies included in this meta-analysis did not provide enough data to examine the effects of age and sex. Except for hippocampal volume, differences be tween left and right brain structures were not mea sured. The statistical test to determine the latter results requires left and right regional volumes, and these data were not generally provided by the original studies. Thus, the possibility that some of the effects found in this meta analysis were caused by confounding factors such as sex and age cannot be ruled out. In addition, some stud ies 11, 48 suggest that white matter reduction reflects an in creased risk of developing schizophrenia. Although the present meta-analysis did not find significant decreases, the analysis resulted in significant heterogeneity, which hampers a reliable interpretation and may have influ enced the results. More and larger studies are needed to show whether in nonpsychotic relatives total brain and white matter volume differ from healthy control sub jects. Longitudinal studies on brain volumes of relatives of schizophrenic patients could also be helpful in dimin ishing problems of individual study characteristics and reducing heterogeneity issues. In addition, different meth ods have been proposed for estimating heterogeneity and publication bias. For example, other meta-analyses have included funnel plots (plots of effect estimates against sample size) to index publication bias 84 and the I 2 statis tic to measure the proportion of inconsistency in indi vidual studies that cannot be explained by chance. The latter approach was argued to be a better index of hetero geneity than the Q statistic, especially for collections of studies with either small or large sample sizes (measur ing inconsistency in meta-analyses). 85 Notably, most stud ies included in our analyses were of intermediate sample size. Finally, some studies included in this meta analysis not only studied first-degree relatives but also included some second-degree relatives. 19, 21, 50 These stud ies did not examine hippocampal and gray matter vol ume. However, in the analysis of third-ventricle vol ume, second-degree relatives were included but the exact amount was not reported in the studies. Excluding the 3 studies that examined some second-degree relatives did not alter the results of our meta-analysis.
In summary, our results provide support for the hy pothesis that nonpsychotic first-degree relatives of pa tients with schizophrenia show structural brain abnor malities, particularly in the left hippocampus. These brain abnormalities are similar to the areas that are affected in patients with schizophrenia and parallel the findings of neuropsychological impairments (especially in verbal memory) in both patients and relatives. Although these findings reflect a vulnerability to developing schizo phrenia, it is still unclear how and to what extent genes and/or environment are involved. Future studies should focus on the search for susceptibility genes in relation to brain abnormalities by using linkage and association methods. 
